ARCHIVES

Von Eschenbach says oncology is undergoing a “revolutionary evolution.”

This article is from The Cancer Letter archive.

Vol. 31 No. 20 | May 20, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Duke’s Gary Lyman to Co-Direct Fred Hutch Outcomes Research

January 10, 2014

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

President’s Budget Request for FDA Omits Funding for Critical Path.

February 8, 2008

NCCS Networker Volume 1 Issue 1, March 1987

March 12, 1987

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002